- Home
- KNSA vs DXC Comparison
KNSA vs DXC Comparison
Compare KNSA & DXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- DXC
- Stock Information
- Founded
- KNSA 2015
- DXC 1959
- Country
- KNSA United Kingdom
- DXC United States
- Employees
- KNSA N/A
- DXC N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- DXC EDP Services
- Sector
- KNSA Health Care
- DXC Technology
- Exchange
- KNSA Nasdaq
- DXC Nasdaq
- Market Cap
- KNSA 2.6B
- DXC 2.6B
- IPO Year
- KNSA 2018
- DXC N/A
- Fundamental
- Price
- KNSA $38.51
- DXC $13.33
- Analyst Decision
- KNSA Strong Buy
- DXC Hold
- Analyst Count
- KNSA 7
- DXC 6
- Target Price
- KNSA $44.00
- DXC $15.60
- AVG Volume (30 Days)
- KNSA 392.4K
- DXC 2.0M
- Earning Date
- KNSA 10-28-2025
- DXC 11-06-2025
- Dividend Yield
- KNSA N/A
- DXC N/A
- EPS Growth
- KNSA N/A
- DXC 384.35
- EPS
- KNSA 0.07
- DXC 2.05
- Revenue
- KNSA $529,332,000.00
- DXC $12,794,000,000.00
- Revenue This Year
- KNSA $37.21
- DXC N/A
- Revenue Next Year
- KNSA $12.07
- DXC N/A
- P/E Ratio
- KNSA $582.26
- DXC $6.52
- Revenue Growth
- KNSA 56.18
- DXC N/A
- 52 Week Low
- KNSA $17.82
- DXC $12.24
- 52 Week High
- KNSA $39.12
- DXC $24.83
- Technical
- Relative Strength Index (RSI)
- KNSA 64.65
- DXC 44.44
- Support Level
- KNSA $37.69
- DXC $13.20
- Resistance Level
- KNSA $38.83
- DXC $14.01
- Average True Range (ATR)
- KNSA 0.95
- DXC 0.47
- MACD
- KNSA 0.00
- DXC -0.05
- Stochastic Oscillator
- KNSA 79.11
- DXC 22.56
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About DXC DXC Technology Company
DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.